Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28251 - 28275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cyclosporine	Approved Investigational Vet Approved	ZWILCH	55055	downregulated	Cyclosporine results in decreased expression of ZWILCH mRNA	15q22.31	A21092 A20661
Cyclosporine	Approved Investigational Vet Approved	ZWINT	11130	downregulated	Cyclosporine results in decreased expression of ZWINT mRNA	10q21-q22	A21092 A20661 A21868
Cyclosporine	Approved Investigational Vet Approved	ZXDA	7789	upregulated	Cyclosporine results in increased expression of ZXDA mRNA	Xp11.21	A21092
Cyclosporine	Approved Investigational Vet Approved	ZXDB	158586	upregulated	Cyclosporine results in increased expression of ZXDB mRNA	Xp11.21	A21868
Cyclosporine	Approved Investigational Vet Approved	ZXDC	79364	upregulated	Cyclosporine results in increased expression of ZXDC mRNA	3q21.3	A21868
Cyclosporine	Approved Investigational Vet Approved	ZYG11B	79699	downregulated	Cyclosporine results in decreased expression of ZYG11B mRNA	1p32.3	A21092 A21868
Cyclosporine	Approved Investigational Vet Approved	ZYX	7791	upregulated	Cyclosporine results in increased expression of ZYX mRNA	7q34	A21868
Cyclosporine	Approved Investigational Vet Approved	ZZZ3	26009	upregulated	Cyclosporine results in increased expression of ZZZ3 mRNA	1p31.1	A21092 A21868
Cyproterone acetate	Approved Investigational	AR	367	downregulated	Cyproterone Acetate results in decreased expression of AR mRNA	Xq12	A20058
Cyproterone acetate	Approved Investigational	AR	367	upregulated	Cyproterone Acetate results in increased expression of AR mRNA	Xq12	A21884
Cyproterone acetate	Approved Investigational	CYP3A4	1576	upregulated	Cyproterone Acetate results in increased expression of CYP3A4 mRNA	7q22.1	A21238
Cysteamine	Approved Investigational	MMP12	4321	upregulated	Cysteamine results in increased expression of MMP12 mRNA	11q22.2	A21885
Cysteamine	Approved Investigational	MMP14	4323	upregulated	Cysteamine results in increased expression of MMP14 mRNA	14q11.2	A21885
Cysteamine	Approved Investigational	MMP9	4318	upregulated	Cysteamine results in increased expression of MMP9 mRNA	20q13.12	A21885
Cytarabine	Approved Investigational	ACAP1	9744	upregulated	Cytarabine results in increased expression of ACAP1 mRNA	17p13.1	A20985
Cytarabine	Approved Investigational	ACTA1	58	upregulated	Cytarabine results in increased expression of ACTA1 mRNA	1q42.13	A21886
Cytarabine	Approved Investigational	ACTC1	70	downregulated	Cytarabine results in decreased expression of ACTC1 mRNA	15q14	A21886
Cytarabine	Approved Investigational	ADAM19	8728	downregulated	Cytarabine results in decreased expression of ADAM19 mRNA	5q33.3	A21886
Cytarabine	Approved Investigational	ADAMTS1	9510	downregulated	Cytarabine results in decreased expression of ADAMTS1 mRNA	21q21.3	A21886
Cytarabine	Approved Investigational	ADAMTS9	56999	downregulated	Cytarabine results in decreased expression of ADAMTS9 mRNA	3p14.1	A21886
Cytarabine	Approved Investigational	ADGRB3	577	upregulated	Cytarabine results in increased expression of ADGRB3 mRNA	6q12-q13	A21886
Cytarabine	Approved Investigational	AFAP1L2	84632	downregulated	Cytarabine results in decreased expression of AFAP1L2 mRNA	10q25.3	A21886
Cytarabine	Approved Investigational	AHNAK	79026	downregulated	Cytarabine results in decreased expression of AHNAK mRNA	11q12.3	A21886
Cytarabine	Approved Investigational	AIF1L	83543	upregulated	Cytarabine results in increased expression of AIF1L mRNA	9q34.12-q34.13	A21886
Cytarabine	Approved Investigational	AKR1B15	441282	downregulated	Cytarabine results in decreased expression of AKR1B15 mRNA	7q33	A21886

Displaying entries 28251 - 28275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability